ALK-Abelló Future Growth
Future criteria checks 4/6
ALK-Abelló is forecast to grow earnings and revenue by 22.7% and 9.6% per annum respectively. EPS is expected to grow by 21.7% per annum. Return on equity is forecast to be 18.2% in 3 years.
Key information
22.7%
Earnings growth rate
21.7%
EPS growth rate
Pharmaceuticals earnings growth | 14.7% |
Revenue growth rate | 9.6% |
Future return on equity | 18.2% |
Analyst coverage | Low |
Last updated | 26 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,483 | 1,275 | 1,073 | 1,431 | 3 |
12/31/2025 | 5,907 | 1,058 | 855 | 1,199 | 5 |
12/31/2024 | 5,350 | 760 | 341 | 767 | 5 |
12/31/2023 | 4,824 | 486 | 288 | 667 | N/A |
9/30/2023 | 4,728 | 424 | 17 | 426 | N/A |
6/30/2023 | 4,680 | 359 | -76 | 343 | N/A |
3/31/2023 | 4,590 | 335 | 90 | 479 | N/A |
12/31/2022 | 4,511 | 335 | 63 | 416 | N/A |
9/30/2022 | 4,361 | 333 | 149 | 489 | N/A |
6/30/2022 | 4,227 | 318 | 163 | 493 | N/A |
3/31/2022 | 4,050 | 255 | 152 | 432 | N/A |
12/31/2021 | 3,916 | 219 | 205 | 468 | N/A |
9/30/2021 | 3,808 | 112 | 273 | 505 | N/A |
6/30/2021 | 3,652 | 55 | 158 | 358 | N/A |
3/31/2021 | 3,556 | 66 | 147 | 358 | N/A |
12/31/2020 | 3,491 | 25 | 79 | 301 | N/A |
9/30/2020 | 3,383 | 43 | 87 | 298 | N/A |
6/30/2020 | 3,350 | 49 | 149 | 353 | N/A |
3/31/2020 | 3,363 | -9 | -14 | 172 | N/A |
12/31/2019 | 3,274 | -50 | -35 | 132 | N/A |
9/30/2019 | 3,178 | -183 | -104 | 59 | N/A |
6/30/2019 | 3,100 | -200 | -211 | -54 | N/A |
3/31/2019 | 3,030 | -149 | -205 | -27 | N/A |
12/31/2018 | 2,915 | -170 | -273 | -95 | N/A |
9/30/2018 | 2,891 | -183 | -394 | -223 | N/A |
6/30/2018 | 2,897 | -152 | -409 | -214 | N/A |
3/31/2018 | 2,873 | -136 | -610 | -386 | N/A |
12/31/2017 | 2,910 | -158 | -654 | -387 | N/A |
9/30/2017 | 2,901 | 37 | N/A | -278 | N/A |
6/30/2017 | 2,864 | 76 | N/A | -146 | N/A |
3/31/2017 | 2,946 | 149 | N/A | 206 | N/A |
12/31/2016 | 3,005 | 270 | N/A | 405 | N/A |
9/30/2016 | 2,938 | 373 | N/A | 492 | N/A |
6/30/2016 | 2,975 | 396 | N/A | 458 | N/A |
3/31/2016 | 2,767 | 378 | N/A | 312 | N/A |
12/31/2015 | 2,569 | 344 | N/A | 183 | N/A |
9/30/2015 | 2,494 | 221 | N/A | 153 | N/A |
6/30/2015 | 2,349 | 185 | N/A | 136 | N/A |
3/31/2015 | 2,399 | 162 | N/A | 258 | N/A |
12/31/2014 | 2,433 | 181 | N/A | 320 | N/A |
9/30/2014 | 2,414 | 205 | N/A | 307 | N/A |
6/30/2014 | 2,401 | 188 | N/A | 330 | N/A |
3/31/2014 | 2,318 | 127 | N/A | 157 | N/A |
12/31/2013 | 2,244 | 61 | N/A | 146 | N/A |
9/30/2013 | 2,266 | 6 | N/A | 98 | N/A |
6/30/2013 | 2,365 | 53 | N/A | 157 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0OIR's forecast earnings growth (22.7% per year) is above the savings rate (1.6%).
Earnings vs Market: 0OIR's earnings (22.7% per year) are forecast to grow faster than the UK market (12.2% per year).
High Growth Earnings: 0OIR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 0OIR's revenue (9.6% per year) is forecast to grow faster than the UK market (3.3% per year).
High Growth Revenue: 0OIR's revenue (9.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0OIR's Return on Equity is forecast to be low in 3 years time (18.2%).